New York State Common Retirement Fund Cuts Position in Cardinal Health, Inc. $CAH

New York State Common Retirement Fund trimmed its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 1.4% during the 3rd quarter, Holdings Channel reports. The fund owned 327,147 shares of the company’s stock after selling 4,601 shares during the period. New York State Common Retirement Fund’s holdings in Cardinal Health were worth $51,349,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CAH. Latitude Advisors LLC increased its position in Cardinal Health by 2.1% in the third quarter. Latitude Advisors LLC now owns 2,598 shares of the company’s stock worth $408,000 after purchasing an additional 53 shares during the last quarter. WESPAC Advisors LLC lifted its position in Cardinal Health by 1.0% during the third quarter. WESPAC Advisors LLC now owns 6,644 shares of the company’s stock valued at $1,043,000 after purchasing an additional 63 shares during the last quarter. Kathmere Capital Management LLC grew its stake in shares of Cardinal Health by 1.6% in the 3rd quarter. Kathmere Capital Management LLC now owns 4,091 shares of the company’s stock worth $642,000 after buying an additional 65 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its stake in shares of Cardinal Health by 0.4% in the 2nd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 17,805 shares of the company’s stock worth $2,991,000 after buying an additional 69 shares in the last quarter. Finally, Vermillion & White Wealth Management Group LLC increased its holdings in shares of Cardinal Health by 55.0% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock worth $34,000 after buying an additional 71 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts recently commented on CAH shares. UBS Group increased their price target on shares of Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a report on Friday, October 31st. Argus upped their price objective on Cardinal Health from $211.00 to $232.00 and gave the company a “buy” rating in a research report on Friday, January 23rd. Mizuho set a $222.00 price objective on Cardinal Health in a research note on Monday, January 12th. Citigroup raised Cardinal Health from a “neutral” rating to a “buy” rating and boosted their target price for the company from $190.00 to $244.00 in a research report on Friday, January 9th. Finally, Evercore ISI increased their price target on Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a report on Friday, October 31st. Fourteen equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $224.73.

Trending Headlines about Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Cardinal hit an all-time high, reinforcing upside momentum and drawing more attention from momentum and trend-following buyers. Cardinal Health stock hits all-time high at $215.54
• Positive Sentiment: Morgan Stanley upgraded competitor Cencora, calling a “golden era” for drug distributors — a sector-level endorsement that likely lifts sentiment for Cardinal as a leading distributor. Cencora upgraded as Morgan Stanley cites a “golden era” for drug distributors
• Positive Sentiment: Multiple brokers and analysts are highlighting CAH as a top pick for Q4/early 2026, citing solid earnings trends and cooled inflation — this increases the likelihood of continued analyst revisions and inflows. 5 Broker-Loved Stocks to Watch Amid Steady Start to Q4 Earnings Season
• Positive Sentiment: Zacks expects CAH to report growing earnings next week and notes the company has the characteristics of a likely earnings beat — a near-term catalyst that can push the stock higher if results confirm expectations. Cardinal Health (CAH) Earnings Expected to Grow: What to Know Ahead of Next Week’s Release
• Positive Sentiment: High-profile bullish commentary (e.g., Jim Cramer saying he can see CAH reaching $300) can attract retail flows and increase trading momentum. Jim Cramer on Cardinal Health: “I Can See That Stock Going to $300”
• Positive Sentiment: IBD highlights raised 2026 guidance and strong momentum, reinforcing the narrative that growth and execution are improving — supports higher valuations. IBD Stock Of The Day: Why Cardinal Health’s Momentum Is ‘Special’ — And Not Over Yet
• Positive Sentiment: Short interest fell ~15.9% in January, lowering potential downside pressure from short-covering dynamics and removing a near-term bearish crowd — fewer shorts can mean steadier rallies. (data summary)
• Neutral Sentiment: Zacks published a valuation-focused piece asking whether CAH is undervalued — useful for longer-term investors but less of an immediate price catalyst. Is Cardinal Health (CAH) Stock Undervalued Right Now?
• Neutral Sentiment: Routine earnings calendar note: Cardinal is expected to announce quarterly results Thursday — the report itself is the key near-term event that could change the stock’s direction. Cardinal Health (CAH) Expected to Announce Quarterly Earnings on Thursday

Cardinal Health Stock Up 0.3%

Shares of Cardinal Health stock opened at $211.02 on Friday. The stock’s fifty day moving average is $206.13 and its two-hundred day moving average is $177.53. Cardinal Health, Inc. has a 52 week low of $120.72 and a 52 week high of $216.51. The company has a market capitalization of $50.14 billion, a PE ratio of 31.83, a price-to-earnings-growth ratio of 1.43 and a beta of 0.65.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping the consensus estimate of $2.22 by $0.33. The business had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The business’s revenue for the quarter was up 22.4% compared to the same quarter last year. During the same period last year, the company earned $1.88 earnings per share. As a group, research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, January 15th. Investors of record on Friday, January 2nd were issued a dividend of $0.5107 per share. The ex-dividend date was Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.